Mechanisms And Prognosis of Stroke-Heart Syndrome

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The incidence of stroke-heart syndrome following acute stroke, which encompasses both acute ischemic stroke and acute intracerebral hemorrhage, is notably high and is strongly associated with increased mortality and poor outcomes in stroke patients. However, the underlying mechanisms remain unclear, and there are currently no effective prevention or treatment strategies. This study aims to elucidate the neuro-humoral mechanisms of stroke-heart syndrome through multimodal imaging and multi-omics blood analysis. Additionally, it seeks to observe the progression of stroke-heart syndrome and its impact on functional outcomes, cognitive abilities, and emotional issues post-stroke. The research is expected to uncover novel blood biomarkers and brain network mechanisms associated with stroke-heart syndrome, providing potential targets and theoretical foundations for pharmacological treatments or physical interventions. Furthermore, it aims to establish a risk early-warning system for major cardiovascular complications post-stroke, enabling early identification, early intervention, and integrated brain-heart management to improve clinical outcomes for stroke patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients admitted within 48 hours of onset, confirmed by CT/MRI as having a stroke (including acute ischemic stroke and hemorrhagic stroke).

• Moderate-to-severe stroke with NIHSS ≥ 5.

Locations
Other Locations
China
Department of Neurology, Tongji hospital, Tongji medical college, Huazhong University of Science and Technology
RECRUITING
Wuhan
Contact Information
Primary
Chensheng Pan, M.D.
pancs29@gmail.com
+8618202738845
Backup
Zhou Zhu, MD, PhD
zhouzhu@hust.edu.cn
+86 18171081029
Time Frame
Start Date: 2025-03-01
Estimated Completion Date: 2028-04-01
Participants
Target number of participants: 658
Sponsors
Leads: Chensheng Pan
Collaborators: National Natural Science Foundation of China

This content was sourced from clinicaltrials.gov